デフォルト表紙
市場調査レポート
商品コード
1750716

臨床意思決定支援システムの市場規模、シェア、動向分析レポート:製品別、用途別、提供形態別、コンポーネント別、地域別、セグメント予測、2025年~2030年

Clinical Decision Support Systems Market Size, Share & Trends Analysis Report By Product (Standalone CDSS, Integrated EHR with CDSS), By Application (Drug-Drug Interactions), By Delivery Mode, By Component, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 135 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
臨床意思決定支援システムの市場規模、シェア、動向分析レポート:製品別、用途別、提供形態別、コンポーネント別、地域別、セグメント予測、2025年~2030年
出版日: 2025年05月08日
発行: Grand View Research
ページ情報: 英文 135 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床意思決定支援システム市場の成長と動向

Grand View Research, Inc.の最新レポートによると、臨床意思決定支援システムの世界市場規模は2030年に107億1,000万米ドルに達すると予測され、2025~2030年にかけて11.0%のCAGRで成長すると予測されています。

臨床意思決定支援システム(CDSS)の採用と統合を促進することを目的とした政府のイニシアチブは、病院や医療機関にそのようなソリューションを導入するインセンティブを与えることにより、市場の成長を促進すると予想されます。例えば、米国保健福祉省(HHS)は2023年4月、臨床意思決定支援ツールの利用拡大を奨励するため、認証プログラムの規則を改定しました。さらに、AIとクラウドベースのCDSS技術の進歩が市場拡大を加速すると予測されます。CDSSプラットフォームとデータベース管理を強化するためのクラウドベースのコンピューティングの導入も、予測期間における市場成長にプラスの影響を与えると予測されています。

COVID-19パンデミックの間、様々な政府機関や地域団体がヘルスケアインフラを強化するための取り組みを開始しました。これらの取り組みは、州当局による最前線のクリニックの設置から、医療専門家のボランティアパネルの動員、民間の遠隔医療プラットフォームの展開まで多岐にわたりました。臨床意思決定支援システム(CDSS)は、この危機的状況において、医師が治療の時点で十分な情報に基づいた意思決定を行う上で不可欠であることが証明されました。

その結果、市場参入企業はこの機会を活用して課題に対処し、最前線の医療提供者を支援しました。例えば、2022年5月、athenahealth, Inc.の子会社であるepocratesは、COVID-19パンデミックによってもたらされた課題をよりよく管理するために、臨床意思決定支援ツールを強化しました。

さらに、複数の企業が臨床意思決定支援システム(CDSS)の提供を強化する戦略を積極的に実施し、市場での地位を固めています。例えば、2024年2月、Elsevier Healthは、医療領域向けにカスタマイズ型AIソリューションの著名なプロバイダであるOpenEvidenceと協業し、米国でClinicalKey AIを発売しました。この協業では、先進的医療コンテンツと生成型人工知能(AI)を統合し、臨床医による患者ケアのやり取りを支援します。

臨床意思決定支援システム市場レポートハイライト

  • 調査ヘルスケアはAIを臨床意思決定支援システム(CDSS)に統合し、膨大なデータを処理して治療戦略を推奨し、潜在的な問題を浮き彫りにし、業務を合理化し、医療専門家を支援しています。
  • スタンドアロンCDSSが2024年に30.7%の最大市場シェアを占めたのは、低コストでシンプルなため広く採用されているからです。標準化や広範な臨床専門知識を必要とせず、実際の患者データがなくても運用できます。
  • 薬剤アレルギー警告は、2024年に25.7%の最大市場シェアを占めました。特定の薬剤にアレルギーを持つ人が何人もいるため、アレルギーアラートを提供するシステムが重要です。
  • CDSSサービスは、医療機関がCDSSソフトウェアの価値を最大化し、臨床意思決定を最適化するための導入、トレーニング、サポート、カスタマイズ、コンサルティングサービスを提供するため、2024年に42.3%の最大市場シェアを占めました。
  • 2024年の市場シェアは、オンプレミス型が41.9%で最大となりました。オンプレミスのCDSSソリューションは、カスタマイズや既存のヘルスケアシステムやワークフローとの統合に柔軟性を提供し、特定の組織のニーズに対応します。
  • 北米の臨床意思決定支援システム市場は、2024年の世界売上高の25.3%を占めました。北米の消費者は、現在の動向、個人のスタイル、個人の表現を反映した臨床意思決定支援システムを優先する傾向があります。
  • 北米の臨床意思決定支援システム市場は、2024年に43.10%以上の収益シェアで世界市場を独占しました。この優位性は、ヘルスケアにおけるITソリューションの需要の高まりと、質の高いヘルスケアサービスの提供に重点を置いていることが背景にあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床意思決定支援システム市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 臨床意思決定支援システム市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 臨床意思決定支援システム市場:製品別、推定・動向分析

  • 製品市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 臨床意思決定支援システム市場:製品別展望
  • スタンドアロン型CDSS
  • CDSS統合型CPOE
  • CDSS統合型EHR
  • CPOE・HER統合型CDSS

第5章 臨床意思決定支援システム市場:用途別、推定・動向分析

  • 用途市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 臨床意思決定支援システム市場:用途別展望
  • 薬剤間相互作用
  • 薬剤アレルギー警告
  • 臨床上の注意点
  • 臨床ガイドライン
  • 薬剤投与サポート
  • その他

第6章 臨床意思決定支援システム市場:提供形態別、推定・動向分析

  • 提供形態市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 臨床意思決定支援システム市場:提供形態別展望
  • Webベースのシステム
  • クラウドベースのシステム
  • オンプレミスシステム

第7章 臨床意思決定支援システム市場:コンポーネント別、推定・動向分析

  • コンポーネント市場シェア、2023年と2030年
  • セグメントダッシュボード
  • コンポーネント別臨床意思決定支援システム市場展望
  • ハードウェア
  • ソフトウェア
  • サービス

第8章 臨床意思決定支援システム市場:地域推定・動向分析

  • 地域別市場シェア分析、2023年と2030年
  • 地域別市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測動向分析、2018~2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • シンガポール
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要販売代理店とチャネルパートナー一覧
    • 主要企業の市場シェア分析、2024年
    • McKesson Corporation
    • Cerner Corporation
    • Siemens Healthineers GmbH
    • Veradigm LLC
    • athenahealth, Inc.
    • NextGen Healthcare Inc.
    • Koninklijke Philips NV(Royal Philips)
    • IBM Corporation
    • Agfa-Gevaert Group
    • Wolters Kluwer NV
    • Becton, Dickinson and Company
    • Cabot Technology Solutions
    • GE HealthCare
    • Nordic
    • BeeKeeperAI
    • BSCO Industries, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 4 North America clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 6 North America clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 15 Mexico clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 16 Mexico clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 18 Mexico. clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 20 Europe clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 21 Europe clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 22 Europe clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 23 U.K. clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 24 U.K. clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 25 U.K. clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 26 U.K. clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 27 Germany clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 30 Germany clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 31 France clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 32 France clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 33 France clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 34 France clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 35 Italy clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 36 Italy clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 37 Italy clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 38 Italy clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 39 Spain clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 40 Spain clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 41 Spain clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 42 Spain clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 43 Sweden clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 44 Sweden clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 45 Sweden clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 46 Sweden clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 47 Denmark clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 48 Denmark clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 50 Denmark clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 51 Norway clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 52 Norway clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 Norway clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 54 Norway clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 59 Japan clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 60 Japan clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 Japan clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 62 Japan clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 63 China clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 64 China clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 65 China clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 66 China clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 67 India clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 68 India clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 69 India clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 70 India clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 71 Australia clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 72 Australia clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 73 Australia clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 74 Australia clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 75 South Korea clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 76 South Korea clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 78 South Korea clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 79 Thailand clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 80 Thailand clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 81 Thailand clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 82 Thailand clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 83 Latin America clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 84 Latin America clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 85 Latin America clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 86 Latin America. clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 87 Brazil clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 88 Brazil clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 90 Brazil clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 91 Argentina clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 92 Argentina clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 93 Argentina clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 95 MEA clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 96 MEA clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 97 MEA clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 98 MEA clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 99 South Africa clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 100 South Africa clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 101 South Africa clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 102 South Africa clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 107 UAE clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 108 UAE clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 109 UAE clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 110 UAE clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)
  • Table 111 Kuwait clinical decision support systems market estimates and forecasts, by product, 2018 - 2030 (USD Million)
  • Table 112 Kuwait clinical decision support systems market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • Table 113 Kuwait clinical decision support systems market estimates and forecasts, by delivery mode, 2018 - 2030 (USD Million)
  • Table 114 Kuwait clinical decision support systems market estimates and forecasts, by component, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical decision support systems market: market outlook
  • Fig. 9 Clinical decision support systems competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical decision support systems market driver impact
  • Fig. 15 Clinical decision support systems market restraint impact
  • Fig. 16 Clinical decision support systems market strategic initiatives analysis
  • Fig. 17 Clinical decision support systems market: Type movement analysis
  • Fig. 18 Clinical decision support systems market: Type outlook and key takeaways
  • Fig. 19 Standalone CDSS market estimates and forecast, 2018 - 2030
  • Fig. 20 Integrated CPOE with CDSS market estimates and forecast, 2018 - 2030
  • Fig. 21 Integrated EHR with CDSS market estimates and forecast, 2018 - 2030
  • Fig. 22 Integrated CDSS with CPOE and EHR market estimates and forecast, 2018 - 2030
  • Fig. 23 Clinical decision support systems market: Application movement analysis
  • Fig. 24 Clinical decision support systems market: Application outlook and key takeaways
  • Fig. 25 Drug-drug interactions market estimates and forecast, 2018 - 2030
  • Fig. 26 Drug allergy alerts market estimates and forecast, 2018 - 2030
  • Fig. 27 Clinical reminders market estimates and forecast, 2018 - 2030
  • Fig. 28 Clinical guidelines market estimates and forecast, 2018 - 2030
  • Fig. 29 Drug dosing support market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 Clinical decision support systems market: Delivery Mode movement analysis
  • Fig. 32 Clinical decision support systems market: Delivery Mode outlook and key takeaways
  • Fig. 33 Web-based systems market estimates and forecast, 2018 - 2030
  • Fig. 34 Cloud-based systems market estimates and forecast, 2018 - 2030
  • Fig. 35 On-premise systems market estimates and forecast, 2018 - 2030
  • Fig. 36 Clinical decision support systems market: Component movement analysis
  • Fig. 37 Clinical decision support systems market: Component outlook and key takeaways
  • Fig. 38 Intranasal market estimates and forecast, 2018 - 2030
  • Fig. 39 External market estimates and forecast, 2018 - 2030
  • Fig. 40 Clinical decision support systems market: End user movement analysis
  • Fig. 41 Clinical decision support systems market: End user outlook and key takeaways
  • Fig. 42 Hardware market estimates and forecast, 2018 - 2030
  • Fig. 43 Software market estimates and forecast, 2018 - 2030
  • Fig. 44 Services market estimates and forecast, 2018 - 2030
  • Fig. 45 Global clinical decision support systems market: Regional movement analysis
  • Fig. 46 Global clinical decision support systems market: Regional outlook and key takeaways
  • Fig. 47 Global clinical decision support systems market share and leading players
  • Fig. 48 North America market share and leading players
  • Fig. 49 Europe market share and leading players
  • Fig. 50 Asia Pacific market share and leading players
  • Fig. 51 Latin America market share and leading players
  • Fig. 52 Middle East & Africa market share and leading players
  • Fig. 53 North America: SWOT
  • Fig. 54 Europe SWOT
  • Fig. 55 Asia Pacific SWOT
  • Fig. 56 Latin America SWOT
  • Fig. 57 MEA SWOT
  • Fig. 58 North America, by country
  • Fig. 59 North America market estimates and forecasts, 2018 - 2030
  • Fig. 60 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 61 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 63 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 64 UK market estimates and forecasts, 2018 - 2030
  • Fig. 65 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 66 France market estimates and forecasts, 2018 - 2030
  • Fig. 67 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 68 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 69 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 70 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 71 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 72 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 73 China market estimates and forecasts, 2018 - 2030
  • Fig. 74 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 75 India market estimates and forecasts, 2018 - 2030
  • Fig. 76 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 77 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 79 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 80 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 81 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 82 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 83 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 85 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 87 Market share of key market players - Clinical decision support systems market
目次
Product Code: GVR-2-68038-339-3

Clinical Decision Support Systems Market Growth & Trends:

The global clinical decision support systems market size is anticipated to reach USD 10.71 billion in 2030 and is projected to grow at a CAGR of 11.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government initiatives aimed at promoting the adoption and integration of Clinical Decision Support Systems (CDSS) are expected to drive market growth by incentivizing hospitals and healthcare organizations to deploy such solutions. For example, in April 2023, the U.S. Department of Health and Human Services (HHS) revised certification program rules to encourage greater utilization of clinical decision support tools. Furthermore, advancements in AI and cloud-based CDSS technologies are projected to accelerate market expansion. The implementation of cloud-based computing to enhance CDSS platforms and database management is also anticipated to positively influence market growth in the forecast period.

During the COVID-19 pandemic, various government and community organizations initiated efforts to bolster the healthcare infrastructure. These initiatives ranged from setting up frontline clinics by state authorities to mobilizing volunteer panels of medical professionals and deploying private telemedicine platforms. Clinical Decision Support Systems (CDSS) proved indispensable during this crisis, assisting physicians in making informed decisions at the point of care.

Consequently, market participants capitalized on this opportunity to address challenges and support frontline healthcare providers. For example, in May 2022, epocrates, a subsidiary of athenahealth, Inc., enhanced its clinical decision support tools to better manage the challenges posed by the COVID-19 pandemic.

Furthermore, several companies are actively implementing strategies to enhance their clinical decision support systems (CDSS) offerings, consolidating their position in the market. For example, in February 2024, Elsevier Health collaborated with OpenEvidence, a prominent provider of AI solutions customized for the medical domain, to launch ClinicalKey AI in the U.S. This collaboration involved integrating advanced medical content with generative artificial intelligence (AI) to assist clinicians in patient-care interactions.

Clinical Decision Support Systems Market Report Highlights:

  • Researchers are integrating AI into Clinical Decision Support Systems (CDSS) to process vast data to recommend treatment strategies, highlight potential issues, streamline operations, and support healthcare professionals.
  • Standalone CDSS held the largest market share of 30.7% in 2024, because it is widely adopted for its low cost and simplicity. They don't require standardization or extensive clinical expertise and can operate without real patient data.
  • Drug allergy alerts accounted for the largest market share of 25.7% in 2024. Several people have allergies to specific drugs, so it is important to have systems that provide allergy alerts
  • CDSS services held the largest market share of 42.3% in 2024, as it offers implementation, training, support, customization, and consulting services to help healthcare organizations maximize the value of CDSS software and optimize clinical decision-making
  • On-premise segment in delivery mode dominated the market with the largest share of 41.9% in 2024. On-premise CDSS solutions offer flexibility for customization and integration with existing healthcare systems and workflows, catering to specific organizational needs.
  • The Clinical Decision Support Systems market in North America accounted for a share of 25.3% of the global revenue in 2024. North American consumers tend to prioritize Clinical Decision Support Systems that reflects current trends, personal style, and individual expression
  • North America clinical decision support systems market dominated the global market with over 43.10% revenue share in 2024. This dominance is fueled by the rising demand for IT solutions in healthcare and the emphasis on delivering quality healthcare services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Delivery Mode
    • 1.1.4. Component
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Delivery mode outlook
    • 2.2.4. Component outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Decision Support Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Adoption of Electronic Health Records (EHRs)
      • 3.2.1.2. Increasing Demand for Quality Care and Patient Safety
      • 3.2.1.3. Advancements in AI and Machine Learning Technologies
      • 3.2.1.4. Supportive Government Initiatives and Healthcare IT Policies
      • 3.2.1.5. Integration of CDSS with Clinical Workflows
      • 3.2.1.6. Need to Reduce Medication Errors and Diagnostic Inaccuracies
      • 3.2.1.7. Emergence of Cloud-Based CDSS Solutions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Implementation and Integration Costs
      • 3.2.2.2. Data Privacy and Security Concerns
      • 3.2.2.3. Interoperability Challenges with Legacy Systems
  • 3.3. Clinical Decision Support Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economical landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Clinical Decision Support Systems Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Decision Support Systems Market by Product Outlook
  • 4.4. Standalone CDSS
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Integrated CPOE with CDSS
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Integrated EHR with CDSS
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Integrated CDSS with CPOE and HER
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Clinical Decision Support Systems Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Decision Support Systems Market by Application Outlook
  • 5.4. Drug-Drug Interactions
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Drug Allergy Alerts
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Clinical Reminders
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Clinical Guidelines
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Drug Dosing Support
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Clinical Decision Support Systems Market: Delivery Mode Estimates & Trend Analysis

  • 6.1. Delivery Modes Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Clinical Decision Support Systems Market by Delivery Modes Outlook
  • 6.4. Web-Based Systems
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Cloud-Based Systems
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. On-Premise Systems
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Clinical Decision Support Systems Market: Component Estimates & Trend Analysis

  • 7.1. Component Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Clinical Decision Support Systems Market by Component Outlook
  • 7.4. Hardware
    • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Software
    • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Services
    • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Clinical Decision Support Systems Market: Regional Estimates & Trend Analysis, By Type, By Application, By Delivery Mode, By Component

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Singapore
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. McKesson Corporation
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Cerner Corporation
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Siemens Healthineers GmbH
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Veradigm LLC
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. athenahealth, Inc.
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiativess
    • 9.3.9. NextGen Healthcare Inc.
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Koninklijke Philips N.V. (Royal Philips)
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. IBM Corporation
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Agfa-Gevaert Group
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Wolters Kluwer N.V.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Becton, Dickinson and Company
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. Cabot Technology Solutions
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Product benchmarking
      • 9.3.15.4. Strategic initiatives
    • 9.3.16. GE HealthCare
      • 9.3.16.1. Company overview
      • 9.3.16.2. Financial performance
      • 9.3.16.3. Product benchmarking
      • 9.3.16.4. Strategic initiatives
    • 9.3.17. Nordic
      • 9.3.17.1. Company overview
      • 9.3.17.2. Financial performance
      • 9.3.17.3. Product benchmarking
      • 9.3.17.4. Strategic initiatives
    • 9.3.18. BeeKeeperAI
      • 9.3.18.1. Company overview
      • 9.3.18.2. Financial performance
      • 9.3.18.3. Product benchmarking
      • 9.3.18.4. Strategic initiatives
    • 9.3.19. BSCO Industries, Inc.
      • 9.3.19.1. Company overview
      • 9.3.19.2. Financial performance
      • 9.3.19.3. Product benchmarking
      • 9.3.19.4. Strategic initiatives